These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9814672)

  • 1. Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells.
    Meroni PL; Del Papa N; Raschi E; Panzeri P; Borghi MO; Tincani A; Balestrieri G; Khamashta MA; Hughes GR; Koike T; Krilis SA
    Lupus; 1998; 7 Suppl 2():S44-7. PubMed ID: 9814672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects.
    Sheng Y; Kandiah DA; Krilis SA
    Lupus; 1998; 7 Suppl 2():S5-9. PubMed ID: 9814663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
    Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
    J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants.
    Arnout J; Vermylen J
    Lupus; 1998; 7 Suppl 2():S23-8. PubMed ID: 9814667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.
    Wang MX; Kandiah DA; Ichikawa K; Khamashta M; Hughes G; Koike T; Roubey R; Krilis SA
    J Immunol; 1995 Aug; 155(3):1629-36. PubMed ID: 7543528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes on beta2-GPI recognized by anticardiolipin antibodies.
    Koike T; Ichikawa K; Kasahara H; Atsumi T; Tsutsumi A; Matsuura E
    Lupus; 1998; 7 Suppl 2():S14-7. PubMed ID: 9814665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
    Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
    J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.
    George J; Gilburd B; Hojnik M; Levy Y; Langevitz P; Matsuura E; Koike T; Shoenfeld Y
    J Immunol; 1998 Apr; 160(8):3917-23. PubMed ID: 9558098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
    Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
    Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
    Pengo V; Biasiolo A; Fior MG
    Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome.
    George J; Blank M; Levy Y; Meroni P; Damianovich M; Tincani A; Shoenfeld Y
    Circulation; 1998 Mar; 97(9):900-6. PubMed ID: 9521339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti beta2-glycoprotein I antibodies: clinical significance.
    Tincani A; Spatola L; Cinquini M; Cattaneo R; Meroni P; Balestrieri G
    Lupus; 1998; 7 Suppl 2():S107-9. PubMed ID: 9814685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity.
    Sheng Y; Sali A; Herzog H; Lahnstein J; Krilis SA
    J Immunol; 1996 Oct; 157(8):3744-51. PubMed ID: 8871678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies.
    Arvieux J; Regnault V; Hachulla E; Darnige L; Berthou F; Youinou P
    Thromb Haemost; 2001 Oct; 86(4):1070-6. PubMed ID: 11686326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity.
    Celli CM; Gharavi AE; Chaimovich H
    Biochim Biophys Acta; 1999 Jan; 1416(1-2):225-38. PubMed ID: 9889373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9.
    Dupuy D'Angeac A; Stefas I; Graafland H; De Lamotte F; Rucheton M; Palais C; Eriksson AK; Bosc P; Rosé C; Chicheportiche R
    Biochem J; 2006 Jan; 393(Pt 1):117-27. PubMed ID: 16097953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site.
    Arai T; Yoshida K; Kaburaki J; Inoko H; Ikeda Y; Kawakami Y; Kuwana M
    Blood; 2001 Sep; 98(6):1889-96. PubMed ID: 11535526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
    Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
    Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.